Vitamin D deficiency is widespread among women with breast cancer. Guidelines currently recommend daily supplementation with 400 IU vitamin D3; however, attainment of a circulating level of 25-hydroxyvitamin D defined as sufficient (that is, ≥75 nmol/l) might not be possible with this level of supplementation, according to data published in the Journal of Clinical Oncology.
Subscribe to Journal
Get full journal access for 1 year
only $17.75 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D and fluoride 250–287 (National Academy Press, Washington, DC, 1997).
Crew, K. D. et al. High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. J. Clin. Oncol. 27, 2151–2156 (2009).
Vieth, R., Chan, P. C. & MacFarlane, G. D. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am. J. Clin. Nutr. 73, 288–294 (2001).
Hollis, B. W. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J. Nutr. 135, 317–322 (2005).
Talwar, S. A., Aloia, J. F., Pollack, S. & Yeh, J. K. Dose response to vitamin D supplementation among postmenopausal African American women. Am. J. Clin. Nutr. 86, 1657–1662 (2007).
Heaney, R. P., Davies, K. M., Chen, T. C., Holick, M. F. & Barger-Lux, M. J. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am. J. Clin. Nutr. 77, 204–210 (2003).
Wactawski-Wende, J. et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N. Engl. J. Med. 354, 684–696 (2006).
Giovannucci, E. et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J. Natl Cancer Inst. 98, 451–459 (2006).
Abbas, S. et al. Serum 25-hydroxyvitamin D and risk of postmenopausal breast cancer—results of a large case–control study. Carcinogenesis 29, 93–99 (2008).
Lappe, J. M., Travers-Gustafson, D., Davies, K. M., Recker, R. R. & Heaney, R. P. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am. J. Clin. Nutr. 85, 1586–1591 (2007).
Bruce W. Hollis is a consultant for DiaSorin.
About this article
Cite this article
Hollis, B. US recommendations fail to correct vitamin D deficiency. Nat Rev Endocrinol 5, 534–536 (2009). https://doi.org/10.1038/nrendo.2009.178
Allergy Asthma & Respiratory Disease (2013)
Journal of Human Lactation (2013)
Endocrine Related Cancer (2013)
PLoS ONE (2011)
Serum levels of 25-hydroxyvitamin D in mothers of Swedish and of Somali origin who have children with and without autism
Acta Paediatrica (2010)